The US Food and Drug Administration has approved Pfizer's rapid-acting nasal spray for the treatment of migraine.. The drug is called Zavzpret. It will be available in pharmacies in July 2023, writes Science Alert.. " It is noted that a phase three study of this drug proved that it relieves pain in some migraine sufferers in just 15 minutes.. " The drug was tested by 1,405 people. Half of them took one dose of the spray, while the rest took a placebo.. Recall that earlier scientists called sleep the cause of migraine. Headaches appeared in the participants of the experiment only a day after intermittent sleep and after several hours of being awake in bed in the hope of falling asleep.. An American cured a migraine with a plant-based diet. Subscribe to our channel https://t. me/korrespondentnet Author: 1.